Zhigang Chen
陈志刚
Zhigang Chen is the founder and CEO of HeTan Intelligence (合碳智能), a Shanghai-based startup building AI-powered robotic systems for pharmaceutical R&D labs . He spent roughly a year teaching himself chemistry and pharmaceutical science to bridge the gap between his engineering background and the needs of lab scientists, visiting facilities firsthand to understand their workflow bottlenecks .
Before founding HeTan, Chen held senior roles across China's internet and healthcare sectors: he was WuXi AppTec's first Chief Digital Officer, where he led AI and digital transformation efforts and saw firsthand how "physical execution" became the scaling bottleneck in CRO growth ; founder of Tencent's medical big data lab ; and chief architect and head of algorithms at Alibaba Health . He also worked in Silicon Valley earlier in his career .
HeTan Intelligence, founded in June 2022 , has developed Talos (also referred to as LabBot), a robotic system for automated drug molecule purification that the company says performs at the level of a human expert with ten years of experience in specific scenarios . The startup raised a 50 million yuan funding round in March 2026, with Yunqi Capital among its backers . Chen's broader vision is to apply a "software-defined hardware" approach across the drug development lifecycle, moving from early-stage R&D into preclinical ADME studies and eventually GxP-compliant production .
AI-generated — may contain errors, please verify.
Coverage
The "OpenAI Moment" for Pharma Labs: HeTan AI Raises 50 Million Yuan, Robot Scientists Step Onto the Lab Bench
The story of robot scientists has only just begun.
HETAN Intelligence Closes 50 Million Yuan Funding Round, as Robots Make Real Inroads into Labs
Veteran founders with backgrounds at Alibaba, Tencent, and WuXi AppTec.
Yunqi Capital Attent!on Podcast | Founders Up and Down the Supply Chain: From Embodiment to Intelligence, How Is AI "Awakening" Robots?
Let's Talk About the Messy Reality of Deployment and Application Bottlenecks
Embodied Intelligence + Drug Discovery = ? C12.ai Unveils Industry's First Pharmaceutical R&D Intelligent Robot | Yunqi Capital
Accelerating Drug Discovery and Development
Vol.05 Has AI "Woken Up" the Robots? A Look at the Many Applications and Bottlenecks of Embodied Intelligence
Large Models+: What New Entry Points, Changes, and Possibilities Lie Ahead? | Yunqi Capital · Riding the AGI+ Wave
Greater Bay Area AGI+ Founders, Assemble!
Yunqi Capital · Riding the AGI Wave | 3 Weeks, 3 Cities: We Spoke with 150+ Founders About New Variables in the AGI Era
Embracing the AGI+ Era
Win-Win Cooperation, Empowering Innovation, Building a Sci-Tech Ecosystem Together | Zhangjiang Group × Yunqi Capital
Actively Building a Sci-Tech Innovation Ecosystem







